RE:RE:Technical IndicatorsThe nov 12 press release with q3 results disclosed 30,000 shares. As I said, I'm not sure what the rules are for NCIB disclosure other than it's different from insiders disclosure. Maybe quarterly in the financial release is all that is required. Try asking the cfo maybe.
pabaloo wrote: Once it gets to cash it should bounce back. Insiders have been buying. I checked Sedi and can't find anything on the buybacks? Not even the 3000 they bought last quarter according to the conference call. Trevyent is going back to the fda In the new year and Trulance should be dealt with as well. Also looking for an announcement on Activis generic launch next week. Waiting to see.